Drug discovery companies identify, validate and develop new therapeutic candidates for the prevention and treatment of disease. The sector combines biology, chemistry, data science and clinical expertise to bring new medicines from concept to clinic.
This category includes companies working on:
Browse 422 UK drug discovery companies below.
Cancer Research UK's translational and commercialisation arm
Cancer Research Horizons is the translational subsidiary of Cancer Research UK, operating at the interface between academic research and industry. The organisation combines…
Tau-targeting therapeutics and diagnostics for neurodegenerative disease
TauRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments and diagnostics for Alzheimer's disease and related neurodegenerative disorders. Its…
Bioanalytical CRO supporting drug development from discovery to post-marketing
York Bioanalytical Solutions is a contract research organisation providing bioanalytical, metabolism and biomarker services to pharmaceutical and biotech companies. The company…
Automated drug discovery platform and CRO services
Arctoris is a technology-enabled contract research organisation that provides automated wet-lab biology and data generation services to biotech and pharmaceutical companies. The…
CRO-CDMO process chemistry and API manufacturing centre for global pharma partners
Sai Life Sciences operates a UK research and development site providing contract research and development and manufacturing services to global biotech and pharmaceutical…
Oral delivery platform for biologics targeting inflammatory diseases
Intract Pharma is a biotechnology company developing proprietary formulation platforms for the oral delivery of complex biologics including monoclonal antibodies and proteins. The…
Non-surgical drug therapy for spinal cord injury recovery
NeuroSolv Therapeutics is a preclinical-stage biotechnology company developing a non-surgical two-part therapy for spinal cord injury. The proposed mechanism combines enzymatic…
Stabilised siRNA therapeutics platform targeting cardiovascular gene silencing
Argonaute RNA is a biopharmaceutical company developing small interfering RNA therapeutics for cardiovascular disease. Its siRNA platform uses proprietary chemical stabilisation…
Light-controlled droplet microfluidics for single-cell functional analysis
Lightcast Discovery is a life science tools company developing a droplet-based system for single-cell functional analysis. Using light to precisely control picolitre-scale…
AI-driven lab automation platform for drug discovery
Astral Automation Solutions is a Welsh software company developing an AI-powered laboratory automation platform for pre-clinical drug discovery. The platform provides intelligent…
Shark-derived single-domain antibody biologics for cancer and inflammation
Elasmogen is a biotechnology company developing next-generation therapeutic biologics based on its proprietary soloMER platform, single-domain antibody-like proteins derived from…
Implantable localised chemotherapy delivery for hard-to-treat solid tumours
CRISM Therapeutics is a clinical-stage drug delivery company developing an implantable biodegradable technology that delivers chemotherapy directly into tumours or surgical…